Derivatization of isolated endogenous butyrobetaine with 4'-bromophenacyl trifluoromethanesulfonate followed by high-performance liquid chromatography.
S Krahenbuhl, P E Minkler, C L Hoppel
Index: J. Chromatogr. A. 573(1) , 3-10, (1992)
Full Text: HTML
Abstract
A method for the isolation and chromatography of butyrobetaine from plasma, urine, and liver is described. The recovery of [3H-methyl]butyrobetaine from spiked biological samples was from 76-80%. Spiked samples then were derivatized with 4'-bromophenacyl trifluoromethanesulfonate and the butyrobetaine 4'-bromophenacyl ester was isolated by high-performance liquid chromatography (HPLC). Radioactivity eluted in a single peak which co-chromatographed with authentic butyrobetaine 4'-bromophenacyl ester. Two identical liver specimens were treated according to this isolation procedure. Prior to derivatization, one specimen was treated with butyrobetaine hydroxylase. After derivatization, there was no butyrobetaine 4'-bromophenacyl ester peak in the specimen treated with butyrobetaine hydroxylase. The HPLC detection sensitivity to butyrobetaine 4'-bromophenacyl ester was 1 pmol injected with a signal-to-noise greater than 2:1.
Related Compounds
Related Articles:
2000-10-20
[J. Chromatogr. A. 895 , 309, (2000)]
1992-11-16
[Clin. Chim. Acta 212 , 55, (1992)]
[J. Chromatogr. A. 613(2) , 203-21, (1993)]
[J. Chromatogr. A. 299(2) , 365-76, (1984)]
2005-03-01
[Anal. Chem. 77(5) , 1448-57, (2005)]